Stockreport

LEO Pharma's eczema cream gains MHRA marketing authorisation [Yahoo! Finance]

JAPAN TOBACCO UNSP/ADR  (JAPAY) 
NASDAQ:AMEX Investor Relations: gungho.co.jp/en/ir
PDF kinase (JAK) inhibitor, Anzupgo (delgocitinib) 20mg/g cream, to treat chronic hand eczema (CHE) in Britain. The approval enables the treatment of adults with moderate [Read more]